GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition
P. Halfon, E. Bestion, K. Zandi, J. Andreani, J.-P. Baudoin, B. LA SCOLA, J.-L. Mege, S. Mezouar, R. F. Schinazi
This study shows GNS561, an autophagy inhibitor, has strong antiviral effects against SARS-CoV-2, both alone and in combination with remdesivir.
bioRxiv · Oct 6, 2020Pathology